Effects of Taping & Exercise Therapy on Lower Back Musculoskeletal Conditions in Pakistani Patients

December 5, 2022 updated by: Kiran Arshad, University of Karachi
Lower back pain has been one of the most frequently occurring musculoskeletal disorder among the females. This act as a global burden and is highly prevalent in our society. This pain can result in life long disability, loss of function and mobility among individuals. The female of the society suffers from lower back pain the most because of the under lying causes, prolong standing and stooping as well as because of hormonal changes in their bodies

Study Overview

Detailed Description

After studying the prevalence of the lower back pain among the females of Pakistan, the investogator find the need to assess the type of their pain and find out the best way to ease their pains. The motive was to develop a treatment protocol whose effects last longer and is inexpensive for the management of lower back pain.

Moreover, the investigator decided to study that which treatment protocol is better when compared to another and what is the role of sham treatment when given to the patients.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan
        • Al-Tibri Medical college and hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

24 years to 34 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females who were willing to participate.
  • Participants with nonspecific lower back pain will only be included and screened through the screening questionnaire.

Exclusion Criteria:

  • Post-menopausal women
  • Females with any diagnosed co-morbidity.
  • Back pain progressive to any neurological deficit
  • Sustained or increased back pain with loss of appetite and unexplained weight loss accompanied with fever, nausea and chills
  • With any known spinal or lower back pathology
  • Tumor of the spine
  • Any underlying diseases of spinal cord (i.e, ankylosing spondylosis, spondolisthesis)
  • With any steroid therapy for lower back pain in the past three months
  • Any inflammatory rheumatic disease
  • Sensitive skin or any skin allergy or dermatological condition
  • Any rehabilitative services taken for the lower back pain in the past two months
  • Rejection to manual conatct

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Myofascial Release (MFR)
The therapist will place its hands on the T12-L1 levels as well as on the sacrum. A cross handed hold will be performed along the fascia. Then for the gluteus Medius and maximus muscle, the therapist will stand facing the participant's leg and closed to the superior border of participant's pelvis. The therapist will place the palm of the hand on the anterior surface, allowing the fingers to rest on the outer fibers of the gluteal muscles stabilizing the pelvis of the participants. Allow the participant to flex its knee while applying adequate amount of stretch on the hip joint in an open pack position. Hold, wait for the release and stretch again. for tensor fascia Latae, The therapist will place several slightly adducted fingers of its one hand on the superior fibers proximal to the insertion on the anterior superior iliac crest and the thumb as well as the other fingers of the other hand on the distal muscle fibers. Hold, wait for the release and stretch again.
Only Myofascial Release will be provided
Other Names:
  • Myofascial Release
Active Comparator: Kinesio Taping (KT)

Lumbar star correction technique was applied. 4 tape I strips will be cut. The paper from the center will be torn. The targeted area will be stretched as tolerated at the lumbar region. The therapist will apply 25% to 35% tension to the strip within the therapeutic zone over the target tissue. End the strip with no tension and activate the adhesive. For the second strip change the posture in order to change the stretch on the tissue, apply the second strip with 25% to 35% tension in the center of the tape and end with no tension. Activate the adhesive. Now flex the trunk and rotate on one side. Apply the third tape strip with 25% to 35% tension in the center of the tape. Apply the fourth tape strip with flexion and rotation on the opposite side again with 25% to 35% tension on the strip.

The tape will be changed 3 times per week.

Only Kinesiotaping will be provided
Other Names:
  • Taping
Experimental: Myofascial Release with Taping (MFKT)
Same Protocol of MFR followed by KT
Myofascial release will be provided followed by Kinesiotaping
Other Names:
  • Therapy followed by taping
Sham Comparator: Placebo Treatment
The control group received a sham myofascial release for 40 minutes per treatment session, three times a week for three weeks. The sham myofascial release was applied by gently placing the hands over the same areas treated in the MFR group,without sliding, just enough to maintain contact for the desired time.
Placebo Treatment will be given

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower Back Pain
Time Frame: Change from baseline to week 3
Numeric Pain Rating Scale
Change from baseline to week 3
Disability of lower back
Time Frame: Change from baseline to week 3
Oswestry Disability Index
Change from baseline to week 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion
Time Frame: Change from baseline to week 3
Flexion, Extension and Lateral Bending (L and R)
Change from baseline to week 3
Pain Pressure Threshold
Time Frame: Change from baseline to week 3
Algometer was used to check the pain pressure threshold of Thoraco lumbar fascia, Gluteus Medius, Gluteus Maximus and Tensor Fascia Latae
Change from baseline to week 3
Tissue Hardness
Time Frame: Change from baseline to week 3
Algometer was used to check the tissue hardness of Thoraco lumbar fascia, Gluteus Medius, Gluteus Maximus and Tensor Fascia Latae
Change from baseline to week 3
Quality of Life of patients with Lower back pain
Time Frame: Change from baseline to week 3
36-Item Short Form Health Survey (SF-36)
Change from baseline to week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kiran Arshad, M.Phil, University of Karachi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

October 20, 2022

Study Completion (Actual)

October 21, 2022

Study Registration Dates

First Submitted

November 19, 2022

First Submitted That Met QC Criteria

December 5, 2022

First Posted (Actual)

December 14, 2022

Study Record Updates

Last Update Posted (Actual)

December 14, 2022

Last Update Submitted That Met QC Criteria

December 5, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Data will be collected in the form of distribution of questionnaire to the participants.

Confidentiality of the participants will be maintained. Consent will be taken form participants before collection of data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Back Pain

Clinical Trials on Therapy

Subscribe